XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Supplemental Financial Information | 6 Months Ended
--- | ---
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Supplemental Financial Information |
4. | Supplemental Financial Information
Inventories
Schedule of inventories |  |  |  |  |  |  |  |
|  | December 31, |  |  | June 30, |
|  | 2024 |  |  | 2024 |
|  | (In thousands) |
Finished goods |  | $ | 17,973 |  |  | $ | 14,167 |
Raw materials |  |  | 11,097 |  |  |  | 13,531 |
Inventories |  | $ | 29,070 |  |  | $ | 27,698 |
Other Liabilities The following table presents details of our other liabilities:
Schedule of other liabilities |  |  |  |  |  |  |  |
|  | December 31, |  |  | June 30, |
|  | 2024 |  |  | 2024 |
|  | (In thousands) |
Current |  |  |  |  |  |  |  |
Accrued variable consideration |  | $ | 2,825 |  |  | $ | 1,796 |
Customer deposits and refunds |  |  | 287 |  |  |  | 436 |
Accrued raw materials purchases |  |  | 170 |  |  |  | 126 |
Deferred revenue |  |  | 2,720 |  |  |  | 3,017 |
Lease liability |  |  | 1,694 |  |  |  | 1,767 |
Taxes payable |  |  | 623 |  |  |  | 772 |
Warranty reserve |  |  | 835 |  |  |  | 840 |
Other accrued operating expenses |  |  | 2,282 |  |  |  | 2,217 |
Total other current liabilities |  | $ | 11,436 |  |  | $ | 10,971 |
Non-current |  |  |  |  |  |  |  |
Lease liability |  | $ | 8,408 |  |  | $ | 8,563 |
Deferred tax liability |  |  | 317 |  |  |  | 179 |
Deferred revenue |  |  | 2,520 |  |  |  | 2,736 |
Total other non-current liabilities |  | $ | 11,245 |  |  | $ | 11,478 |
Computation of Net Loss per Share Basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the applicable period. The following table presents the computation of net loss per share:
Schedule of computation of net per share |  |  |  |  |  |  |  |  |  |  |  |
|  | Three Months Ended December 31, |  |  | Six Months Ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | (In thousands, except per share data) |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (2,372 | ) |  | $ | (2,593 | ) |  | $ | (4,874 | ) |  | $ | (4,479 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding - basic and diluted |  |  | 38,631 |  |  |  | 37,354 |  |  |  | 38,330 |  |  |  | 37,170 |
Net loss per share - basic and diluted |  | $ | (0.06 | ) |  | $ | (0.07 | ) |  | $ | (0.13 | ) |  | $ | (0.12 | )
The following table presents the common stock equivalents excluded from the diluted net loss per share calculation, because they were anti-dilutive for the periods presented. These excluded common stock equivalents could be dilutive in the future.
Schedule of anti dilutive securities |  |  |  |  |  |  |  |  |  |  |  |
|  | Three Months Ended December 31, |  |  | Six Months Ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | (In thousands) |
Common stock equivalents |  |  | 508 |  |  |  | 608 |  |  |  | 543 |  |  |  | 560 |
Intangible Assets The following table presents details of intangible assets:
Schedule of intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | December 31, 2024 |  |  | June 30, 2024 |
|  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Net Book Value |  |  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Net Book Value |
|  | (In thousands) |
Developed technology |  | $ | 6,770 |  |  | $ | (5,878 | ) |  | $ | 892 |  |  | $ | 6,331 |  |  | $ | (5,293 | ) |  | $ | 1,038 |
Customer relationships |  |  | 18,640 |  |  |  | (15,229 | ) |  |  | 3,411 |  |  |  | 17,528 |  |  |  | (13,315 | ) |  |  | 4,213 |
Order backlog |  |  | 273 |  |  |  | – |  |  |  | 273 |  |  |  | – |  |  |  | – |  |  |  | – |
Trademark and trade name |  |  | 88 |  |  |  | – |  |  |  | 88 |  |  |  | – |  |  |  | – |  |  |  | – |
|  | $ | 25,771 |  |  | $ | (21,107 | ) |  | $ | 4,664 |  |  | $ | 23,859 |  |  | $ | (18,608 | ) |  | $ | 5,251 |
We do not currently have any intangible assets with indefinite useful lives. As of December 31, 2024, future estimated amortization expense is as follows:
Schedule of future estimated amortization expense |  |  |  |
Years Ending June 30, |  |  |
(In thousands) |  |  |
2025 (remainder) |  | $ | 1,479 |
2026 |  |  | 1,631 |
2027 |  |  | 621 |
2028 |  |  | 338 |
2029 |  |  | 273 |
Thereafter |  |  | 322 |
Total future amortization |  | $ | 4,664 |
Restructuring, Severance and Related Charges During the three and six months ended December 31, 2024, we incurred charges of approximately $193,000 and $1,093,000, respectively, related to certain headcount reductions in our sales, engineering, and operations groups. We may incur additional charges in future periods as we identify additional cost savings and efficiencies related to our business. The following table presents details of the liability we recorded related to restructuring, severance and related activities:
Schedule of severance and related charges |  |  |  |
|  | Six Months Ended |
|  | December 31, |
|  | 2024 |
|  | (In thousands) |
Beginning balance |  | $ | 253 |
Charges |  |  | 1,093 |
Payments |  |  | (1,194 | )
Ending balance |  | $ | 152 |
These balances are recorded in accrued payroll and related expenses in the accompanying unaudited condensed consolidated balance sheets. In January 2025, we undertook a reduction in our labor force to better align staffing needs with our business objectives. We expect the severance and related charges in connection with this action to approximate $1,300,000 to $1,500,000, which will be recorded in the three months ending March 31, 2025. Supplemental Cash Flow Information The following table presents non-cash investing transactions excluded from the accompanying unaudited condensed consolidated statements of cash flows:
Schedule of non-cash investing transactions |  |  |  |  |  |
|  | Six Months Ended December 31, |
|  | 2024 |  |  | 2023 |
|  | (In thousands) |
Accrued property and equipment paid for in the subsequent period |  | $ | 14 |  |  | $ | 24 |

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration